Literature DB >> 21113811

Clinical and laboratory characteristics of patients with sickle-cell and autoimmune/connective tissue diseases.

Salam Alkindi1, Mustafa Al-Maini, Anil Pathare.   

Abstract

Patients with sickle-cell disease who develop autoimmune connective tissue disorders can present with similar clinical manifestations and/or complications making them indistinguishable. We report here a single-institution study on a cohort of 24 patients, with the above combination. The results suggest that there is often a significant delay in making the second diagnosis because of the overlapping clinical profile. It is emphasized that the clinician should be aware of and vigilant about such cases and should diligently follow up such cases to make an early diagnosis and start the appropriate treatment.

Entities:  

Mesh：

Year:  2010        PMID： 21113811     DOI： 10.1007/s00296-010-1632-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  25 in total

Review 1.  Cytokines in sickle cell disease.

Authors:  Anil Pathare; Salam Al Kindi; Shahina Daar; David Dennison
Journal:  Hematology       Date:  2003-10       Impact factor: 2.269

Review 2.  Systemic lupus erythematosus.

Authors:  Anisur Rahman; David A Isenberg
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 3.  Sickle cell nephropathy during the postpartum period in a patient with SLE.

Authors:  P T Pham; S Q Lew; J E Balow
Journal:  Am J Kidney Dis       Date:  1997-12       Impact factor: 8.860

4.  Sickle cell anemia and SLE.

Authors:  N L Luban; R L Boeckx; O Barr
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

5.  Hemoglobin sickle cell disease and systemic lupus erythematosus.

Authors:  R P Warrier; S Sahney; H Walker
Journal:  J Natl Med Assoc       Date:  1984-10       Impact factor: 1.798

6.  SLE and sickle cell disease.

Authors:  G Karthikeyan; S L Wallace; L Blum
Journal:  Arthritis Rheum       Date:  1978 Sep-Oct

7.  Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.

Authors:  Martin Aringer; Winfried B Graninger; Günter Steiner; Josef S Smolen
Journal:  Arthritis Rheum       Date:  2004-10

8.  Serum autoantibodies in patients with sickle cell anemia.

Authors:  F P Quismorio; C Johnson
Journal:  Am J Med Sci       Date:  1984 Jan-Feb       Impact factor: 2.378

9.  Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.

Authors:  M Michel; A Habibi; B Godeau; D Bachir; A Lahary; F Galacteros; A Fifi-Mah; S Arfi
Journal:  Semin Arthritis Rheum       Date:  2008-01-04       Impact factor: 5.532

10.  Systemic lupus erythematosus in children with sickle cell disease.

Authors:  Vinay Raj Saxena; Rina Mina; Hamid J Moallem; Sreedhar P Rao; Scott T Miller
Journal:  J Pediatr Hematol Oncol       Date:  2003-08       Impact factor: 1.289
View more
  3 in total

1.  Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease.

Authors:  Shreya Bali; David D'Cruz; Marion Lazaro; Baba P D Inusa
Journal:  BMJ Case Rep       Date:  2015-03-27

Review 2.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

3.  Serum Immunoglobulin Levels in Children with Sickle Cell Disease: A Large Prospective Study.

Authors:  Sophia Cherif-Alami; Isabelle Hau; Cécile Arnaud; Annie Kamdem; Basil Coulon; Elodie Idoux; Stéphane Bechet; Rita Creidy; Françoise Bernaudin; Ralph Epaud; Corinne Pondarré
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.